As Japan Struggles To Rebuild After Tremors: Here's What Survivors May Face

Updated Jan 16, 2025 | 02:00 AM IST

SummaryGen X or Generation X is a term used to describe people who were born between the mid-1960s and 1980s. New research has revealed rising cancer risk among individuals aged 45-60.
Earthquake

On Monday night, a magnitude 6.6 earthquake struck Japan, leading to a tsunami warning. Fortunately, authorities reported minimal damage, and the warning was soon lifted. According to local media, there was only one minor injury involving a man who fell at his own home.

Japan, located in the Pacific Ring of Fire, experiences approximately 1,500 tremors annually. However, these quakes have a long-lasting impact on one's health—both physical and mental.

Health Impacts Of Earthquakes

1. Wound Infections

Earthquake-related injuries range from cuts and bruises to fractures and crush injuries. If not attended to on time, these wounds can lead to infections like sepsis, tetanus, or even amputations if untreated. Regions with scarce medical resources face higher risks of untreated injuries and antimicrobial resistance. Ensuring prompt medical care and deploying teams to assess building safety is critical to preventing further injuries and fatalities.

A recent study examined infections in 225 earthquake survivors with musculoskeletal injuries treated between February and April 2023. It found that gram-negative bacteria were common in the wounds of the victims. Acinetobacter baumannii (49.4%) and enterococci (28.6%) were the most prevalent. Many pathogens were multidrug-resistant, with 76% from wound cultures and 58% from deep tissue cultures showing resistance. Common infections included surgical site infections (32.8%), urinary tract infections (5.3%), bloodstream infections (5.7%), and pneumonia (0.4%). Intensive care was required for 35.6% of patients, with a mortality rate of 2.7%.

2. Infectious Diseases

Earthquakes disrupt water supplies, leading to unsanitary conditions that spread waterborne diseases such as cholera. Meanwhile, it also pushes people to take shelters in dingy places, which can outbreaks of measles, respiratory illnesses, and parasitic infections like leishmaniasis. Cold conditions and stress suppress immunity, increasing the risk of disease spread.

3. Chronic Conditions

Access to medication and medical care is often disrupted by earthquakes. Studies show increased rates of heart attacks, strokes, and diabetes following earthquakes due to stress and disrupted routines. Destruction of health records and facilities exacerbates these issues, especially in disaster-prone regions.

4. Healthcare Disruption

Damaged medical facilities and transport links hinder healthcare delivery. Pregnant women and individuals with chronic diseases face heightened risks. Refugees and displaced populations encounter accessibility barriers to healthcare services.

5. Psychological Trauma

Survivors of these earthquakes often suffer from anxiety, depression, and Post Traumatic Stress Disorder (PTSD). Tailored mental health programs are crucial for recovery, especially for those already living in conflict zones or displacement.

On April 14 2010, a 7.1-magnitude earthquake struck Qinghai Province, China, devastating Yushu County. A psychological relief study, published in the Journal Of Affective Disorders in 2011, assessed the mental health of 505 survivors three to four months post-disaster. Using tools like the PTSD Checklist-Civilian version (PCL-C) and Hopkins Symptoms Checklist-25 (HSCL-25), the study found prevalence rates of 33.7% for probable PTSD, 43.8% for anxiety, and 38.6% for depression, with one-fifth of participants experiencing all three. Key risk factors included being female, experiencing intense fear during the quake, and having limited social support, as measured by the Perceived Social Support Scale (PSSS).

End of Article

Why Metabolic Fatty Liver Disease Is Rising as India’s Most Common Liver Condition

Updated Apr 11, 2026 | 08:59 PM IST

SummaryMASLD is strongly linked to obesity, sedentary lifestyles, and metabolic syndrome. Genetic susceptibility also plays a role — variants in genes such as PNPLA3 are associated with increased liver fat accumulation, particularly in certain Indian populations.
Why Metabolic Fatty Liver Disease Is Rising as India’s Most Common Liver Condition

Credit: Canva

Metabolism-Associated Fatty Liver Disease (MAFLD) — also termed Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — is defined by excess hepatic fat accumulation (>5 per cent of liver weight) in the presence of metabolic dysfunction, independent of alcohol intake. It encompasses a spectrum from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma.

MAFLD: Epidemiology In India

A Lancet Regional Health study found that approximately 39 per cent of Indian adults screened had fatty liver disease, making it one of the most prevalent chronic liver conditions in the country. Within India, prevalence shows regional variation driven by genetic, dietary, and socioeconomic factors.

A particularly important feature is the “lean MAFLD” phenotype — South Asians often develop fatty liver at a lower BMI due to disproportionately high visceral fat, which complicates detection based on conventional BMI screening. Currently, MASLD is the commonest cause of liver cirrhosis and hepatocellular carcinoma (HCC).

MAFLD: Causes And Risk Factors

The core drivers are components of metabolic syndrome: type 2 diabetes mellitus, obesity (particularly central adiposity), dyslipidemia, hypertension, and insulin resistance. MASLD is strongly linked to obesity, sedentary lifestyles, and metabolic syndrome.

Genetic susceptibility also plays a role — variants in genes such as PNPLA3 are associated with increased liver fat accumulation, particularly in certain Indian populations. Rapid dietary transition towards ultra-processed, high-calorie foods compounds the risk.

MAFLD: Investigations

Routine liver function tests may appear normal in early stages, and an ultrasound detects only moderate-to-severe fat accumulation. A structured approach includes:

  • Blood tests: LFTs, fasting glucose, HbA1c, lipid profile, insulin resistance indices
  • Ultrasound abdomen: First-line imaging for steatosis
  • FibroScan (Transient Elastography): Liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) are standardized non-invasive tools for assessing fibrosis and steatosis.
  • Liver biopsy: Gold standard for staging steatohepatitis and fibrosis when non-invasive tests are inconclusive.

MAFLD: Treatment

No approved pharmacotherapy exists exclusively for MAFLD; management is lifestyle-centred:

  • Weight loss: 7–10 per cent body weight reduction significantly reduces hepatic steatosis and inflammation
  • Diet: Mediterranean-style diet; restrict refined carbohydrates and saturated fats
  • Exercise: Both aerobic and resistance training improve insulin sensitivity and liver fat
  • Metabolic comorbidity control: Optimise glycaemia (GLP-1 agonists show hepatic benefit), manage dyslipidaemia and hypertension
  • Emerging therapies: Resmetirom (thyroid hormone receptor-β agonist) has shown promise in MASH with fibrosis.
In 2024, India’s Union Ministry of Health and Family Welfare integrated NAFLD/MASLD into the National Program for Non-Communicable Diseases, reflecting growing policy recognition of its public health burden.

End of Article

Parkinson’s at 40: Why Younger Adults Are Being Diagnosed Earlier Than Before

Updated Apr 12, 2026 | 12:00 AM IST

SummaryWhile the symptoms of the disease are mostly the same at whatever age it develops, younger people will experience the disease differently due to their unique life circumstances. Managing the disease can be particularly challenging for a younger person and their family from a medical, psychological, and social standpoint.
Parkinson’s at 40: Why Younger Adults Are Being Diagnosed Earlier Than Before

Credit: Canva

Once known to affect only people over 60, Parkinson’s Disease is now increasingly being seen in young adults, especially at the age of 40, said health experts on World Parkinson’s Day today.

World Parkinson’s Day is observed every year on April 11 to raise awareness about the brain condition that causes tremors, slowness of movement, and trouble walking.

Parkinson’s is a progressive and neurodegenerative movement disorder caused by the loss of dopamine-producing brain cells.

Progressive decline in mobility is a key issue among Parkinson's patients, impacting their independence and quality of life. Other problems include slow movement, tremor, imbalance, cognitive impairment, mental health disorders, sleep disorders, and pain.

Also read: World Parkinson's Day 2026: Origin, Theme And Global Burden

Young-onset Parkinson’s Disease

According to the American Parkinson's Disease Association, a diagnosis of Parkinson’s between the ages of 21 and 50 is referred to as early-onset Parkinson’s disease, or young-onset Parkinson’s disease (YOPD).

Exposure to environmental toxins and lifestyle changes are major reasons for the rise in Parkinson's in this group.

While the symptoms of the disease are mostly the same at whatever age it develops, younger people will experience the disease differently due to their unique life circumstances. Managing the disease can be particularly challenging for a younger person and their family from a medical, psychological, and social standpoint.

"There is a perceived increase in younger-onset Parkinson’s in India. Possible reasons include better awareness and diagnosis (more neurologists, improved access to care), environmental exposures (pesticides, heavy metals), and air/water pollution. Lifestyle (sedentary habits) and urbanization-related factors may also contribute," Dr Sudhir Kumar, Neurologist at Apollo Hospitals Hyderabad, told HealthandMe.

A 2022 study, published in NPJ Parkinson's Disease, showed that the incidence of Parkinson’s disease, or the number of new cases diagnosed per year, is 50 per cent higher than previously estimated.

Instead of past estimates of 60,000 new cases of Parkinson’s disease diagnosed per year, the study determined that there are approximately 90,000 new cases of Parkinson's disease diagnosed in the US per year.

"Young-onset Parkinson’s disease (YOPD) is on the rise, mainly in the middle socio-demographic index. These countries include India, China, and some Southeast Asian countries," Dr Paresh Doshi, Director of Neurosurgery and Stereotactic & Functional Neurosurgery at Jaslok Hospital and Research Centre.

"According to one research paper, the age-standardized incidence rate has been rising at an alarming rate of 1.4 per cent per annum. To put it in perspective, if the incidence was 100/10,00,000 in 1995, it would be 153/10,00,000 in 2026," he added.

The experts noted that, along with the rising disability burden, mortality is reducing. The compound effect of all these is a larger number of YOPD patients suffering longer. Surgeries like deep-brain stimulation can help reduce these disabilities significantly.

Checklist for Parkinson’s: Signs You Should Not Ignore

Early recognition is critical, as many symptoms precede motor features by years.

Common early signs include:

  • Reduced sense of smell (anosmia)
  • Slowness of movement (bradykinesia)
  • Reduced arm swing while walking
  • Resting tremor
  • Masked facies (reduced facial expression)
  • Change in handwriting (micrographia)

Other important symptoms, which are often overlooked:

  • Constipation
  • Sleep disturbances (especially REM sleep Behavior disorder)
  • Depression or anxiety.

End of Article

The Gut-Brain Axis: How Diet May Influence Parkinson’s Disease

Updated Apr 11, 2026 | 02:00 PM IST

SummaryGut-targeted interventions are promising adjuncts to conventional Parkinson's therapy, improving patients' quality of life. Changes in the gut microbiome may influence inflammation, α-synuclein aggregation, and symptom progression.
The Gut-Brain Axis: How Diet May Influence Parkinson’s Disease

Credit: Canva

Parkinson’s Disease is traditionally characterized by motor symptoms such as tremor and dyskinesia, although non-motor symptoms, in particular gastrointestinal (GI) symptoms such as constipation and incomplete emptying, are often the first markers of the disease and may precede the motor symptoms by years.

GI dysfunction is reported in approximately 70-80 per cent of Parkinson’s patients, mediated in large part through the gut-brain axis (GBA).

Speaking to HealthandMe, Dr Paresh Doshi, Director of Neurosurgery and Stereotactic and Functional Neurosurgery at Jaslok Hospital and Research Center, GBA, is an established two-way network that links the GI tract and the central nervous system (CNS). The connection is multifaceted, involving the vagus nerve, the enteric nervous system (ENS), the immune system, and a vast number of microbial metabolites and neuroendocrine signals.

“Constipation is seen in 66 per cent of Parkinson’s patients, attributed to disordered central and peripheral parasympathetic disruption, and can lead to alteration of the gut microbiome, which in turn worsens constipation, starting a feedback loop,” the doctor explained.

What Parkinson’s Patients Must Eat

Dr Sudhir Kumar, Neurologist at Apollo Hospitals Hyderabad, told HealthandMe that changes in the gut microbiome may influence inflammation, α-synuclein aggregation, and symptom progression.

Practical dietary principles for Parkinson’s patients include:

  • Prefer fiber-rich, plant-based foods (vegetables, fruits, whole grains), which support gut microbiota
  • Include fermented foods (curd, buttermilk), which may improve microbial diversity
  • Reduce ultra-processed and pro-inflammatory foods
  • Ensure adequate hydration (helps reduce the risk of constipation, a common non-motor symptom)
  • Protein timing matters: Levodopa competes with amino acids for absorption.
Hence, lowering protein intake at breakfast and lunch and shifting the bulk of protein to dinner can improve drug response in selected patients with motor fluctuations.

These gut-targeted interventions are promising adjuncts to conventional Parkinson's therapy, and improving patient quality of life.

Parkinson’s Treatment With Dance, Art

Beyond gut-brain axis, research has proven that unconventional therapy, like dance and art, can improve Parkinson’s treatment.

A 2024 study published in the Scientific Reports found that tango, particularly Argentine tango, improved Parkinson's symptoms like thinking problems or balance issues. It also led to a significant improvement in recognizing emotions on people's faces.

Dr Kumar said dance therapy improves balance, gait, and coordination; provides rhythmic cueing, which enhances motor performance, and improves mood and motivation (dopamine-related pathways).

Similarly, art therapy has been shown to improve overall visual-cognitive skills and visual exploration strategies as well as general motor function in patients with Parkinson’s. The changes in brain connectivity highlight a functional reorganization of visual networks, as revealed by a study published in Parkinsonism & Related Disorders.

Dr Kumar said art and creative therapies are also helpful in enhancing cognitive engagement. It may help with executive function and emotional well-being and provide a non-verbal outlet for expression. However, these therapies work best as adjuncts, not replacements, to standard treatment, the expert noted.

World Parkinson’s Day 2026

World Parkinson's Day is observed annually on April 11 to raise global awareness of Parkinson’s disease, the world's fastest-growing neurodegenerative disorder.

It highlights the need for early diagnosis, research, and support for the nearly 10 million people living with the condition. The day marks the birthday of Dr. James Parkinson, who first described the disease in 1817.

The theme of World Parkinson's Day 2026 is "Bridge the Care Gap." It reflects a critical challenge that persists despite advances in medical research: many people living with Parkinson's still lack consistent access to specialist care, affordable treatment, and integrated support systems.

Parkinson's disease affected 11.9 million people in 2021 and will affect 25.2 million people globally by 2050, representing an alarming 112 per cent rise.

End of Article